NCT00874185View on ClinicalTrials.gov

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

CompletedOBSERVATIONAL
Enrollment

720

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Erectile Dysfunction
All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00874185 - Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk | Biotech Hunter | Biotech Hunter